Suven Pharmaceuticals Ltd.(IN:COHANCE)
₹464.55+21.20 (+4.78%)
IN:COHANCE
Suven Pharmaceuticals Ltd. earnings date
₹464.55
At close:+21.20 (+4.78%)
Want to see IN:COHANCE full AI Analyst Report?
Suven Pharmaceuticals Ltd. (COHANCE) Earnings Dates, Call Summary & Reports
3 Followers
Earnings Data
- Estimated Report Date
- Feb 08, 2027
- Period Ending
- 2027 (Q3)
- Consensus EPS Forecast
- 0.91
- Last Year’s EPS
- 0.97
TBA (Not Confirmed)
Same Quarter Last Year
Suven Pharmaceuticals Ltd. (IN:COHANCE) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced.
IN:COHANCE Q2 2027 Earnings Report
IN:COHANCE Upcoming Earnings
Suven Pharmaceuticals Ltd.'s next earnings date is estimated for February 8, 2027, based on past reporting schedules.
IN:COHANCE Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release | Slides | Play Transcript |
|---|---|---|---|---|---|---|---|
| Feb 08, 2027 | 2027 (Q3) | 0.91- | 0.97 | ― | ― | ― | ― |
| Nov 06, 2026 | 2027 (Q2) | -0.040.20 | 1.9 | -89.47% (-1.70) | ― | ― | |
| Aug 05, 2026 | 2027 (Q1) | -0.60-0.60 | 1.6 | -137.50% (-2.20) | ― | ― | |
| May 12, 2026 | 2026 (Q4) | 1.140.90 | 3.5 | -74.29% (-2.60) | ― | ― | |
| Feb 12, 2026 | 2026 (Q3) | 2.690.97 | 3.42 | -71.49% (-2.44) | ― | ― | |
| Nov 12, 2025 | 2026 (Q2) | 1.551.90 | 3.2 | -40.63% (-1.30) | ― | ― | |
| Aug 13, 2025 | 2026 (Q1) | 1.591.60 | 2.4 | -33.33% (-0.80) | ― | ― | |
| May 28, 2025 | 2025 (Q4) | 3.403.50 | 2.1 | 66.67% (+1.40) | ― | ― | |
| Feb 12, 2025 | 2025 (Q3) | ―3.42 | 2 | 71.00% (+1.42) | ― | ― | |
| Nov 12, 2024 | 2025 (Q2) | ―3.20 | 3 | 6.67% (+0.20) | ― | ― |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous quarter.
Beat Missed
IN:COHANCE Earnings-Related Price Changes
| Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 06, 2026 | ₹433.55 | ₹443.35 | +2.26% |
| Aug 05, 2026 | ₹428.95 | ₹439.85 | +2.54% |
| May 12, 2026 | ₹485.75 | ₹457.15 | -5.89% |
| Feb 12, 2026 | ₹350.60 | ₹315.60 | -9.98% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after its recent earnings reports.
FAQ
When does Suven Pharmaceuticals Ltd. (IN:COHANCE) report earnings?
Suven Pharmaceuticals Ltd. (IN:COHANCE) is estimated to report earnings on Feb 08, 2027, TBA (Not Confirmed). The date is an estimate based on past reporting schedules and may change.
What is IN:COHANCE EPS forecast?
IN:COHANCE EPS forecast for the fiscal quarter 2027 (Q3) is 0.91.
